Eisai
4523.T
#2265
Rank
A$12.20 B
Marketcap
A$43.27
Share price
-1.64%
Change (1 day)
-2.04%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2023: A$0.79 Billion

According to Eisai's latest financial reports the company's current earnings are A$5.06 Billion. In 2023 the company made an earning of A$0.79 Billion, an increase over its 2022 earnings that were of -A$34.41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2023

Annual earnings

Year Earnings Change
2023A$0.79 B-2404.04%
2022-A$34.41 Million-103.6%
2021A$0.95 B-39.81%
2020A$1.58 B7.44%
2019A$1.47 B17.22%
2018A$1.26 B86.16%
2017A$0.67 B-23.52%
2016A$0.88 B26.97%
2015A$0.69 B22.3%
2014A$0.57 B-46.07%
2013A$1.05 B-21.85%
2012A$1.35 B-20.59%
2011A$1.70 B-8.91%
2010A$1.87 B19.21%
2009A$1.57 B